Cargando…

IMPACT OF KRAS MUTATIONS IN CLINICAL FEATURES IN COLORECTAL CANCER

BACKGROUND: KRAS mutations are important events in colorectal carcinogenesis, as well as negative predictors of response to EGFR inhibitors treatment. AIM: To investigate the association of clinical-pathological features with KRAS mutations in colorectal cancer patients treated. METHODS: Data from 6...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZANATTO, Renato Morato, SANTOS, Gianni, OLIVEIRA, Júnea Caris, PRACUCHO, Eduardo Marcucci, NUNES, Adauto José Ferreira, LOPES-FILHO, Gaspar Jesus, SAAD, Sarhan Sydney
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Colégio Brasileiro de Cirurgia Digestiva 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743328/ https://www.ncbi.nlm.nih.gov/pubmed/33331426 http://dx.doi.org/10.1590/0102-672020200003e1524

Ejemplares similares

Profile of patients with gastrointestinal stromal tumors (GIST)
por: PRACUCHO, Eduardo Marcucci, et al.
Publicado: (2015)

Health-related quality of life after gastric cancer treatment in Brazil: Narrative review and reflections
por: Pinheiro, Rodrigo Nascimento, et al.
Publicado: (2021)

Influence of the centralizing gastric cancer surgery on the health-related quality of life in Brazil
por: Pinheiro, Rodrigo Nascimento, et al.
Publicado: (2023)

Metalloproteinases and colorectal cancer. Correlation of gene expression and clinical-pathological parameters
por: Morini, Sandra Regina, et al.
Publicado: (2020)

MINILAPAROSCOPIC APPENDECTOMY
por: COLETTA, Lúcio Américo Della, et al.
Publicado: (2016)

The Rapunzel Syndrome: An Unusual Trichobezoar Presentation
por: Lopes, Luiz Roberto, et al.
Publicado: (2010)

Clinical features and KRAS mutation in colorectal cancer with bone metastasis
por: Park, Hyung Soon, et al.
Publicado: (2020)

KRAS Assessment Following ESMO Recommendations for Colorectal Liver Metastases. Is It Always Worth It?
por: Morató, Olga, et al.
Publicado: (2022)

Colorectal cancers with a residual adenoma component: Clinicopathologic features and KRAS mutation
por: Lee, Hyoun Wook, et al.
Publicado: (2022)

Therapeutic Targets of KRAS in Colorectal Cancer
por: Rahman, Shafia, et al.
Publicado: (2021)

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer
por: Guedes, Joana G, et al.
Publicado: (2013)

Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation
por: Pang, Xue-Lian, et al.
Publicado: (2017)

KRAS and TP53 Mutations in Colorectal Carcinoma
por: Al-Kuraya, Khawla S.
Publicado: (2009)

Impact of KRAS Mutations on Management of Colorectal Carcinoma
por: Sullivan, Kevin M., et al.
Publicado: (2011)

KRAS mutant colorectal tumors: Past and present
por: Brand, Toni M., et al.
Publicado: (2012)

KRAS and BRAF genotyping of synchronous colorectal carcinomas
por: GIANNINI, RICCARDO, et al.
Publicado: (2014)

KRAS Transitions and Villous Growth in Colorectal Adenomas
por: Risio, Mauro, et al.
Publicado: (2005)

KRAS-associated microRNAs in colorectal cancer
por: Ibrahim, Hamizah, et al.
Publicado: (2020)

KRAS mutations in patients with colorectal cancer in Libya
por: Abudabous, Asma, et al.
Publicado: (2021)

The Therapeutic Landscape for KRAS-Mutated Colorectal Cancers
por: Tria, Simon Manuel, et al.
Publicado: (2023)

MASTICATORY FUNCTION OF OBESE CANDIDATES TO BARIATRIC SURGERY FROM DISTINCT SOCIOECONOMIC CLASSES
por: PASSERI, Celso Roberto, et al.
Publicado: (2016)

Oncogenic Kras drives invasion and maintains metastases in colorectal cancer
por: Boutin, Adam T., et al.
Publicado: (2017)

Heparan Sulfate Proteoglycans in Human Colorectal Cancer
por: Vicente, Carolina Meloni, et al.
Publicado: (2018)

KRAS mutational analysis for colorectal cancer: Application: Pharmacogenomic
por: Wang, Grace, et al.
Publicado: (2010)

Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab
por: Dunn, Emily F., et al.
Publicado: (2010)

Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
por: Arrington, Amanda K., et al.
Publicado: (2012)

Novel KRAS Gene Mutations in Sporadic Colorectal Cancer
por: Naser, Walid M., et al.
Publicado: (2014)

Personalized treatment for advanced colorectal cancer: KRAS and beyond
por: Patel, Gargi Surendra, et al.
Publicado: (2013)

Prognostic Value of KRAS Mutations in Colorectal Cancer Patients
por: Koulouridi, Asimina, et al.
Publicado: (2022)

Sourcing the immune system to induce immunogenic cell death in Kras-colorectal cancer cells
por: Cirone, Mara, et al.
Publicado: (2019)

Mapping the KRAS proteoform landscape in colorectal cancer identifies truncated KRAS4B that decreases MAPK signaling
por: Adams, Lauren M., et al.
Publicado: (2022)

Molecular Characterization of Acquired Resistance to KRAS(G12C)–EGFR Inhibition in Colorectal Cancer
por: Yaeger, Rona, et al.
Publicado: (2023)

Oxaliplatin-Based Chemotherapy Is More Beneficial in KRAS Mutant than in KRAS Wild-Type Metastatic Colorectal Cancer Patients
por: Lin, Yu-Lin, et al.
Publicado: (2014)

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
por: Kim, Mi-Jung, et al.
Publicado: (2012)

Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer
por: Hiraki, Masayuki, et al.
Publicado: (2015)

KRAS-specific antibody binds to KRAS protein inside colorectal adenocarcinoma cells and inhibits its localization to the plasma membrane
por: Lam, Kuen Kuen, et al.
Publicado: (2023)

Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma
por: Stefanius, Karoliina, et al.
Publicado: (2011)

Characterization of rare transforming KRAS mutations in sporadic colorectal cancer
por: Tong, Joanna HM, et al.
Publicado: (2014)

KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma
por: PALIOGIANNIS, PANAGIOTIS, et al.
Publicado: (2014)

Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
por: Palomba, Grazia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h3i0jslh5oh8ddbgfogvs7giq7